BIORELIANCE LTD.

Active Aberdeen

Other professional, scientific and technical activities n.e.c.

767 employees website.com
Other professional, scientific and technical activities n.e.c.
B

BIORELIANCE LTD.

Other professional, scientific and technical activities n.e.c.

Founded 9 Feb 1990 Active Aberdeen, United Kingdom 767 employees website.com
Other professional, scientific and technical activities n.e.c.

Previous Company Names

MICROBIOLOGICAL ASSOCIATES LTD. 28 Oct 1993 — 4 Jul 1997
MICROBIOLOGICAL ASSOCIATES INTERNATIONAL, LTD. 9 Feb 1990 — 28 Oct 1993
Accounts Submitted 23 Jun 2025 Next due 30 Sept 2026 5 months remaining
Confirmation Submitted 4 Mar 2026 Next due 23 Feb 2027 9 months remaining
Net assets £124M £11M 2024 year on year
Total assets £145M £10M 2024 year on year
Total Liabilities £21M £1M 2024 year on year
Charges 3
3 satisfied

Contact & Details

Contact

Registered Address

13 Queens Road Aberdeen AB15 4YL

Telephone

0800 000 0000

Website

www.example.com

Full company profile for BIORELIANCE LTD. (SC122851), an active company based in Aberdeen, United Kingdom. Incorporated 9 Feb 1990. Other professional, scientific and technical activities n.e.c.. View financials, directors, shareholders, and filings.

Business Summary

This company specializes in providing innovative solutions and services across multiple sectors.

Products & Services

consulting software analytics integration

Reports

Credit Report

In-depth credit score, financial analysis, risk assessment and company intelligence.

Financials

Financials

Period 1 Jan → 31 Dec 2024
Type Total Exemption Full
Next accounts 31 December 2025
Due by 30 September 2026 9 months

Balance Sheet & P&L (2014–2024)

Cash in Bank

£735.00k

Decreased by £326.00k (-31%)

Net Assets

£123.52M

Increased by £10.88M (+10%)

Total Liabilities

£21.47M

Decreased by £1.10M (-5%)

Turnover

£173.25M

Increased by £9.38M (+6%)

Employees

767

Increased by 13 (+2%)

Debt Ratio

15%

Decreased by 2 (-12%)

Financial History

Revenue, profit, EBITDA and key financial figures

2024
Dec Year End
2023
Dec Year End
P&L
Revenue
£142.3M
£128.7M
Gross Profit
£48.2M
£43.1M
Operating Profit
£22.4M
£19.8M
Net Profit
£18.1M
£15.9M
EBITDA
£31.5M
£28.2M
Assets
Cash
£24.7M
£21.3M
Total Assets
£89.4M
£82.1M
Liabilities
Total Liabilities
£45.2M
£41.8M
Key Metrics
Employees
1,247
1,156
Latest Revenue
£142.3M
Latest EBITDA
£31.5M
Cash Position
£24.7M

Funding

Fundraising & Grants

No fundraising or grants recorded

Investors (0)

No investor information available

Officers

Officers

0 active 3 resigned
Status

No officers found

No officers found

Shareholders

Shareholders (1)

Bioreliance U.k. Acquisition Limited
100.0%
5,768,404

Persons with Significant Control

Persons with Significant Control (1)

1 Active 1 Ceased

Merck Kgaa

Germany

Active
Notified 6 Dec 2022
Nature of Control
  • Ownership Of Shares 75 To 100 Percent,voting Rights 75 To 100 Percent,right To Appoint And Remove Directors
Ceased

Group Structure

Group Structure

BIORELIANCE LTD. Current Company

Charges

Charges

3 satisfied

Properties

Properties

0 total

No related properties

Documents

Company Filings

DateCategoryDescriptionDocument
4 Mar 2026Confirmation StatementConfirmation statement made on 9 Feb 2026 with no updates
23 Jun 2025AccountsAnnual accounts made up to 31 Dec 2024
10 Feb 2025Confirmation StatementConfirmation statement made on 9 Feb 2025 with no updates
30 Aug 2024AccountsAnnual accounts made up to 31 Dec 2023
11 Apr 2024OfficersTermination of David Hannah Mcclelland as director on 31 Mar 2024
4 Mar 2026 Confirmation Statement

Confirmation statement made on 9 Feb 2026 with no updates

23 Jun 2025 Accounts

Annual accounts made up to 31 Dec 2024

10 Feb 2025 Confirmation Statement

Confirmation statement made on 9 Feb 2025 with no updates

30 Aug 2024 Accounts

Annual accounts made up to 31 Dec 2023

11 Apr 2024 Officers

Termination of David Hannah Mcclelland as director on 31 Mar 2024

Recent Activity

Latest Activity

Confirmation statement made on 9 Feb 2026 with no updates

1 months ago on 4 Mar 2026

Annual accounts made up to 31 Dec 2024

10 months ago on 23 Jun 2025

Confirmation statement made on 9 Feb 2025 with no updates

1 years ago on 10 Feb 2025

Annual accounts made up to 31 Dec 2023

1 years ago on 30 Aug 2024

Termination of David Hannah Mcclelland as director on 31 Mar 2024

2 years ago on 11 Apr 2024